Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07725185Enrolling by invitation
Randomised, double-blind trial of remimazolam in Myocardial injury (2 arms), sponsored by The Affiliated Hospital of Jiaxing University. Primary endpoint: High-sensitivity cardiac troponin T. Started Aug 2026; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07725185.